Healthcare provider profile · identity verified

Robert Francis Linn, DO

Family Practice · DAYTON, OH · NPI 1225085210

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	476	150
Gabapentin	Gabapentin	430	95
Omeprazole	Omeprazole	351	108
Amlodipine Besylate	Amlodipine Besylate	283	91
Lisinopril	Lisinopril	282	86
Albuterol Sulfate Hfa	Albuterol Sulfate	252	94
Levothyroxine Sodium	Levothyroxine Sodium	234	73
Losartan Potassium	Losartan Potassium	222	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	215	41
Pantoprazole Sodium	Pantoprazole Sodium	214	56
Trazodone Hcl	Trazodone Hcl	208	44
Metformin Hcl	Metformin Hcl	206	50
Sertraline Hcl	Sertraline Hcl	159	43
Metformin Hcl Er	Metformin Hcl	151	46
Hydrochlorothiazide	Hydrochlorothiazide	150	51
Metoprolol Tartrate	Metoprolol Tartrate	134	44
Furosemide	Furosemide	129	50
Lorazepam	Lorazepam	124	27
Baclofen	Baclofen	123	31
Fluticasone Propionate	Fluticasone Propionate	120	47
Tamsulosin Hcl	Tamsulosin Hcl	116	41
Glipizide Er	Glipizide	114	33
Famotidine	Famotidine	104	29
Duloxetine Hcl	Duloxetine Hcl	103	28
Methocarbamol	Methocarbamol	101	31
Rosuvastatin Calcium	Rosuvastatin Calcium	100	35
Tizanidine Hcl	Tizanidine Hcl	100	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	97	30
Metoprolol Succinate	Metoprolol Succinate	97	29
Ibuprofen	Ibuprofen	93	23
Hydralazine Hcl	Hydralazine Hcl	90	27
Alprazolam	Alprazolam	87	15
Eliquis	Apixaban	87	17
Montelukast Sodium	Montelukast Sodium	85	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	83	20
Zolpidem Tartrate	Zolpidem Tartrate	81	14
Fluoxetine Hcl	Fluoxetine Hcl	78	19
Pravastatin Sodium	Pravastatin Sodium	78	25
Buspirone Hcl	Buspirone Hcl	77	20
Prednisone	Prednisone	77	56
Hydroxyzine Hcl	Hydroxyzine Hcl	76	25
Citalopram Hbr	Citalopram Hydrobromide	75	17
Mirtazapine	Mirtazapine	75	16
Allopurinol	Allopurinol	73	19
Jardiance	Empagliflozin	73	25
Atenolol	Atenolol	72	24
Clopidogrel	Clopidogrel Bisulfate	72	24
Simvastatin	Simvastatin	71	24
Tramadol Hcl	Tramadol Hcl	67	26
Meloxicam	Meloxicam	66	18
Dicyclomine Hcl	Dicyclomine Hcl	64	19
Ozempic	Semaglutide	63	12
Potassium Chloride	Potassium Chloride	63	20
Spironolactone	Spironolactone	63	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	14
Naproxen	Naproxen	61	25
Carvedilol	Carvedilol	60	21
Ondansetron Odt	Ondansetron	57	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	19
Trulicity	Dulaglutide	55	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	14
Ipratropium Bromide	Ipratropium Bromide	52	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	49	15
Venlafaxine Hcl Er	Venlafaxine Hcl	49	15
Bupropion Xl	Bupropion Hcl	48	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	13
Diclofenac Sodium	Diclofenac Sodium	42	17
Escitalopram Oxalate	Escitalopram Oxalate	42	16
Hydroxyzine Pamoate	Hydroxyzine Pamoate	42	11
Promethazine Hcl	Promethazine Hcl	42	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	41	27
Azithromycin	Azithromycin	40	36
Lovastatin	Lovastatin	40	suppressed
Fenofibrate	Fenofibrate	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	17
Clonazepam	Clonazepam	36	suppressed
Januvia	Sitagliptin Phosphate	36	12
Meclizine Hcl	Meclizine Hcl	36	18
Ropinirole Hcl	Ropinirole Hcl	36	14
Mounjaro	Tirzepatide	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	29
Propranolol Hcl Er	Propranolol Hcl	33	suppressed
Pregabalin	Pregabalin	32	suppressed
Cephalexin	Cephalexin	31	22
Glimepiride	Glimepiride	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	11
Azelastine Hcl	Azelastine Hcl	29	12
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Fluconazole	Fluconazole	28	19
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Methylprednisolone	Methylprednisolone	27	23
Aripiprazole	Aripiprazole	26	suppressed
Mupirocin	Mupirocin	26	13
Clonidine Hcl	Clonidine Hcl	25	suppressed
Glipizide	Glipizide	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Finasteride	Finasteride	24	suppressed
Nystatin	Nystatin	24	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Linzess	Linaclotide	21	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Fluocinonide	Fluocinonide	19	12
Amoxicillin	Amoxicillin	18	14
Nifedipine Er	Nifedipine	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Topiramate	Topiramate	17	suppressed
Torsemide	Torsemide	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Etodolac	Etodolac	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Primidone	Primidone	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Nitroglycerin	Nitroglycerin	14	11
Xarelto	Rivaroxaban	14	suppressed
Diazepam	Diazepam	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Estradiol	Estradiol	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Repaglinide	Repaglinide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error